Predictive Factors for Silibinin Monotherapy in Patients With Chronic Hepatitis C and Nonresponse to PEG-IFN/RBV Therapy

被引：0
|
作者：
Rutter, Karoline
Stattermayer, Albert
Reiberger, Thomas
Aberle, Judith H.
Zinober, Kerstin
Scherzer, Thomas-Matthias
Beinhardt, Sandra
Holzmann, Heidemarie
Steindl-Munda, Petra
Hofer, Harald
Ferenci, Peter
机构：
来源：
GASTROENTEROLOGY | 2010年 / 138卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1257
引用
收藏
页码：S214 / S215
页数：2
相关论文
共 50 条
  • [1] PREDICTIVE FACTORS FOR SILIBININ MONOTHERAPY IN PATIENTS WITH CHRONIC HEPATITIS C AND NONRESPONSE TO PEG-IFN/RBV THERAPY
    Rutter, K.
    Staettermayer, A.
    Reiberger, T.
    Aberle, J.
    Zinober, K.
    Scherzer, T. -M.
    Beinhardt, S.
    Holzmann, H.
    Steindl-Munda, P.
    Hofer, H.
    Ferenci, P.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S124 - S124
  • [2] Efficacy of Rikkunshito on Anorexia in Chronic Hepatitis C Patients During PEG-IFN/RBV Therapy
    Arai, Makoto
    Matsumura, Tomoaki
    Maruoka, Daisuke
    Nakagawa, Tomoo
    Katsuno, Tatsuro
    Imazeki, Fumio
    Yokosuka, Osamu
    GASTROENTEROLOGY, 2013, 144 (05) : S568 - S568
  • [3] Hepatitis C Virus Genotypes Circulating in Patients With Chronic Hepatitis C in Thailand and Their Responses to Combined PEG-IFN and RBV Therapy
    Kumthip, Kattareeya
    Chusri, Pattranuch
    Pantip, Chansom
    Thongsawat, Satawat
    O'Brien, Amornrat
    Nelson, Kenrad E.
    Maneekarn, Niwat
    JOURNAL OF MEDICAL VIROLOGY, 2014, 86 (08) : 1360 - 1365
  • [4] Association of hypoglycemia and PEG-IFN therapy in chronic hepatitis C
    Li, JJ
    Cubbedge, L
    Foster, K
    Gonsalez, T
    Lambiase, L
    GASTROENTEROLOGY, 2002, 123 (01) : 76 - 76
  • [5] Efficacy of PEG-IFN/RBV and benefit from viral eradication against HCC in chronic hepatitis C patients in Japan
    Asahina, Yasuhiro
    Izumi, Namiki
    Hirayama, Itsuko
    Sato, Mitsuaki
    Tanaka, Tomohiro
    Komatsu, Nobutoshi
    Umeda, Naoki
    Hosokawa, Takanori
    Ueda, Ken
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Itakura, Jun
    Kurosaki, Masayuki
    Uchihara, Masakatsu
    Miyake, Shozo
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A114 - A114
  • [6] EVALUATION OF PREDICTIVE FACTORS ASSOCIATED WITH SUSTAINED VIRAL RESPONSE TO PEG-IFN PLUS RIBAVIRIN COMBINATION THERAPY IN JAPANESE CHRONIC HEPATITIS C PATIENTS
    Hashimoto, Hiroaki
    Itoh, Yoshito
    Minami, Masahito
    Yasui, Kohichiroh
    Mitsuyoshi, Hironori
    Yamaguchi, Kanji
    Iwai, Masaki
    Okanoue, Takeshi
    Yoshikawa, Toshikazu
    HEPATOLOGY, 2008, 48 (04) : 863A - 863A
  • [7] Open, randomized, multicentre Italian trial on PEG-IFN plus ribavirin versus PEG-IFN monotherapy for chronic hepatitis C in HIV-coinfected patients on HAART
    Cargnel, A
    Angeli, E
    Mainini, A
    Gubertini, G
    Giorgi, R
    Schiavini, M
    Duca, P
    ANTIVIRAL THERAPY, 2005, 10 (02) : 309 - 317
  • [8] Examination of the optimal dose of RBV in the PEG-IFN/RBV/TVR combination therapy
    Karino, Yoshiyasu
    Kimura, Mutuumi
    Arakawa, Tomohiro
    Nakajima, Tomoaki
    Kuwata, Yasuaki
    Ozeki, Itaru
    Sato, Takahiro
    Ohmura, Takumi
    Hige, Shuhei
    Toyota, Joji
    HEPATOLOGY, 2013, 58 : 1161A - 1161A
  • [9] PEG-IFNα/RBV Combination Therapy for Chronic Hepatitis C Patients Increases Serum Ferritin Level while It Improves Sustained Viral Response Rate
    Yada, Norihisa
    Kudo, Masatoshi
    Chung, Hobyung
    Hayaishi, Sosuke
    Takita, Masahiro
    Ueda, Taisuke
    Tatsumi, Chie
    Hatanaka, Kinuyo
    Kitai, Satoshi
    Ishikawa, Emi
    Inoue, Tatsuo
    Hagiwara, Satoru
    Ueshima, Kazuomi
    INTERVIROLOGY, 2010, 53 (01) : 60 - 65
  • [10] SAFETY AND EFFICACY OF PEG-IFN/RBV THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C AND HIGH TITRES OF SERUM AUTOANTIBODIES: A SUB-ANALYSIS OF THE MIST STUDY
    D'Ambrosio, R.
    Rumi, M.
    Aghemo, A.
    Prati, G.
    Soffredini, R.
    Donato, M. F.
    De Nicola, S.
    Colombo, M.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S149 - S149
12345